Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2018 | 10-2017 | 07-2017 | 04-2017 | 01-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96 | 101 | 88 | 166 | 114 |
| Receivables | 97 | 91 | 102 | 92 | 140 |
| Inventories | 96 | 96 | 31 | 28 | 45 |
| TOTAL | $288 | $288 | $221 | $286 | $299 |
| Non-Current Assets | |||||
| PPE Net | 91 | 105 | 112 | 133 | 138 |
| TOTAL | $91 | $105 | $112 | $133 | $138 |
| Total Assets | $379 | $394 | $333 | $420 | $437 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48 | 62 | 68 | 73 | 57 |
| Accrued Expenses | 191 | 195 | 26 | 24 | 29 |
| TOTAL | $250 | $273 | $112 | $114 | $101 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $250 | $273 | $112 | $114 | $101 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 4,192 | 0 | 0 | 0 |
| Retained earnings | -4,241 | -4,259 | -4,138 | -4,082 | -4,043 |
| Other shareholders' equity | 178 | 188 | 166 | 195 | 187 |
| TOTAL | $129 | $121 | $221 | $306 | $336 |
| Total Liabilities And Equity | $379 | $394 | $333 | $420 | $437 |